Intervertebral implant

Abstract
An adjustable spinal fusion intervertebral implant including upper and lower body portions each having proximal and distal surfaces at proximal and distal ends thereof. The implant can include a proximal wedge member disposed at the proximal ends of the respective ones of the upper and lower body portions, and a distal wedge member disposed at the distal ends of the respective ones of the upper and lower body portions. First and second linkages can connect the upper and lower body portions. Rotation of an actuator shaft can cause the distal and proximal wedge members to be drawn together such that longitudinal movement of the distal wedge member against the distal surfaces and the longitudinal movement of the proximal wedge member against the proximal surfaces causes separation of the upper and lower body portions.
Description
BACKGROUND

Field


The present invention relates to medical devices and, more particularly, to an intervertebral implant.


Description of the Related Art


The human spine is a flexible weight bearing column formed from a plurality of bones called vertebrae. There are thirty three vertebrae, which can be grouped into one of five regions (cervical, thoracic, lumbar, sacral, and coccygeal). Moving down the spine, there are generally seven cervical vertebra, twelve thoracic vertebra, five lumbar vertebra, five sacral vertebra, and four coccygeal vertebra. The vertebra of the cervical, thoracic, and lumbar regions of the spine are typically separate throughout the life of an individual. In contrast, the vertebra of the sacral and coccygeal regions in an adult are fused to form two bones, the five sacral vertebra which form the sacrum and the four coccygeal vertebra which form the coccyx.


In general, each vertebra contains an anterior, solid segment or body and a posterior segment or arch. The arch is generally formed of two pedicles and two laminae, supporting seven processes—four articular, two transverse, and one spinous. There are exceptions to these general characteristics of a vertebra. For example, the first cervical vertebra (atlas vertebra) has neither a body nor spinous process. In addition, the second cervical vertebra (axis vertebra) has an odontoid process, which is a strong, prominent process, shaped like a tooth, rising perpendicularly from the upper surface of the body of the axis vertebra. Further details regarding the construction of the spine may be found in such common references as Gray's Anatomy, Crown Publishers, Inc., 1977, pp. 33-54, which is herein incorporated by reference.


The human vertebrae and associated connective elements are subjected to a variety of diseases and conditions which cause pain and disability. Among these diseases and conditions are spondylosis, spondylolisthesis, vertebral instability, spinal stenosis and degenerated, herniated, or degenerated and herniated intervertebral discs. Additionally, the vertebrae and associated connective elements are subject to injuries, including fractures and torn ligaments and surgical manipulations, including laminectomies.


The pain and disability related to the diseases and conditions often result from the displacement of all or part of a vertebra from the remainder of the vertebral column. Over the past two decades, a variety of methods have been developed to restore the displaced vertebra to their normal position and to fix them within the vertebral column. Spinal fusion is one such method. In spinal fusion, one or more of the vertebra of the spine are united together (“fused”) so that motion no longer occurs between them. Thus, spinal fusion is the process by which the damaged disc is replaced and the spacing between the vertebrae is restored, thereby eliminating the instability and removing the pressure on neurological elements that cause pain.


Spinal fusion can be accomplished by providing an intervertebral implant between adjacent vertebrae to recreate the natural intervertebral spacing between adjacent vertebrae. Once the implant is inserted into the intervertebral space, osteogenic substances, such as autogenous bone graft or bone allograft, can be strategically implanted adjacent the implant to prompt bone in-growth in the intervertebral space. The bone ingrowth promotes long-term fixation of the adjacent vertebrae. Various posterior fixation devices (e.g., fixation rods, screws etc.) can also be utilize to provide additional stabilization during the fusion process.


Recently, intervertebral implants have been developed that allow the surgeon to adjust the height of the intervertebral implant. This provides an ability to intra-operatively tailor the intervertebral implant height to match the natural spacing between the vertebrae. This reduces the number of sizes that the hospital must keep on hand to match the variable anatomy of the patients.


In many of these adjustable intervertebral implants, the height of the intervertebral implant is adjusted by expanding an actuation mechanism through rotation of a member of the actuation mechanism. In some intervertebral implants, the actuation mechanism is a screw or threaded portion that is rotated in order to cause opposing plates of the implant to move apart. In other implants, the actuation mechanism is a helical body that is counter-rotated to cause the body to increase in diameter and expand thereby.


Furthermore, notwithstanding the variety of efforts in the prior art described above, these intervertebral implants and techniques are associated with another disadvantage. In particular, these techniques typically involve an open surgical procedure, which results higher cost, lengthy in-patient hospital stays and the pain associated with open procedures.


Therefore, there remains a need in the art for an improved intervertebral implant. Preferably, the implant is implantable through a minimally invasive procedure. Further, such devices are preferably easy to implant and deploy in such a narrow space and opening while providing adjustability and responsiveness to the clinician.


SUMMARY OF THE INVENTION

Certain aspects of this disclosure are directed toward an adjustable spinal fusion intervertebral implant. The implant can include upper and lower body portions each having proximal and distal surfaces at proximal and distal ends thereof. The proximal and distal surfaces of the upper and lower body portions can generally face each other. The implant can include a proximal wedge member disposed at the proximal ends of the respective ones of the upper and lower body portions, and a distal wedge member disposed at the distal ends of the respective ones of the upper and lower body portions. The implant can include first and second linkages each connected to the upper and lower body portions. The implant can include an actuator shaft received between the upper and lower body portions. The actuator shaft can extend intermediate the distal and proximal wedge members. Rotation of the actuator shaft can cause the distal and proximal wedge members to be drawn together such that longitudinal movement of the distal wedge member against the distal surfaces and the longitudinal movement of the proximal wedge member against the proximal surfaces causes separation of the upper and lower body portions. The implant features described in the specification can be included in any of the implant embodiments.


In some embodiments, The proximal surfaces of the respective ones of the upper and lower body portions each define a proximal slot therein, and distal surfaces of the respective ones of the upper and lower body portions each define a distal slot therein. In certain aspects, the slots of the proximal and distal surfaces of the upper and lower body portions are generally dove-tailed. In certain aspects, the proximal wedge member and the distal wedge member can each include upper and lower guide members extending at least partially into the respective ones of the proximal and distal slots of the upper and lower body portions with at least a portion of the proximal wedge member and the distal wedge member contacting the proximal and distal surfaces of the upper and lower body portions. The guide members of the proximal and distal wedge members can be generally dovetailed.


In some embodiments, each of the upper and lower body portions can include a first side portion having an extending portion and a second side portion having a receiving portion. The first side portion of the upper body portion can be configured to mate with the second side portion of the lower body portion. The second side portion of the upper body portion can be configured to mate with the first side portion of the lower body portion. In certain aspects, the first and second side portions of the upper body portion can be configured to disengage from the first and second side portions of the lower body portion when the implant is in an expanded state.


In some embodiments, the proximal and distal surfaces of the upper and lower body portions can be sloped.


In some embodiments, the upper and lower body portions comprise generally arcuate respective upper and lower exterior engagement surfaces.


In some embodiments, the proximal wedge member can include an anti-rotational element. The anti-rotational engagement can be configured to engage an implant tool to prevent rotation of the implant when the actuator shaft is rotated relative to the implant. In certain aspects, the anti-rotational element can include a pair of apertures extending into the proximal wedge member.


In some embodiments, each of the first and second linkages can include at least one cam path. In certain aspects, a pin can extend from the at least one cam path to one of the upper and lower body portions.


In some embodiments, a length of the implant varies from about 45 mm to about 54 mm and/or a height of the implant varies from about 6.5 mm to about 12 mm during the separation of the upper and lower body portions. In certain aspects, the length of the implant varies from about 21 mm to about 31 mm during the separation of the upper and lower body portions.


In some embodiments, the upper and lower body portions can be coated with a bio-active coating, including, but not limited to, a hydroxyapatite coating, a titanium plasma spray, a resorbable blast media coating, or composite coatings.


Certain aspects of this disclosure are directed toward a method of manufacturing an adjustable spinal fusion intervertebral implant. The method can include extending an actuator shaft from a proximal wedge member to a distal wedge member. The method can include engaging the proximal and distal wedge members with each of the upper and lower body portions. The method can include connecting first and second linkages to each of the upper and lower body portions. The method of manufacturing steps described in the specification can be included in any of the embodiments discussed herein.


In some embodiments, extending the actuator shaft from the proximal wedge member to the distal wedge member can include inserting the actuator shaft through a central aperture of the proximal wedge member and through a central aperture of the distal wedge member.


In some embodiments, engaging the proximal and distal wedge members with each of the upper and lower body portions can include extending upper and lower guide members of the proximal and distal wedge members at least partially into respective ones of proximal and distal slots of the upper and lower body portions.


In some embodiments, the method can include engaging a first side portion of the upper body portion and a second side portion of the lower body portion. The first side portion can have an extending portion, and the second side portion can have a receiving portion. The receiving portion can be configured to receive the extending portion.


In some embodiments, engaging the first and second linkages with each of the upper and lower body portions can include extending a pin from a cam path of one of the first and second linkages to one of the upper and lower body portions.


In some embodiments, the method can include shot-peening the upper and lower body portions.


In some embodiments, the method can include coating the upper and lower body portions with a bio-active coating, including, but not limited to, a hydroxyapatite coating, a titanium plasma spray, a resorbable blast media coating, or composite coatings.


Certain aspects of this disclosure are directed toward a method of implanting an expandable intervertebral implant. The method can include positioning the implant between two vertebral bodies. The method can include rotating a screw mechanism of the implant to cause proximal and distal wedge members to converge toward each other and engage respective ones of proximal and distal surfaces of upper and lower body portions of the implant. The method can include separating the upper and lower body portions to cause the implant to expand. In certain aspects, separating the upper and lower body portions can cause first and second linkages to rotate from a first configuration to a second configuration. The method of use steps discussed in the specification can be included in any of the embodiments described herein.


In some embodiments, a height of the first and second linkages can be greater in the second configuration than in the first configuration.


In some embodiments, the method can include moving one or more pins along a respective cam path of one of the first and second linkages to cause the first and second linkages to rotate from the first configuration to the second configuration.


For purposes of summarizing the disclosure, certain aspects, advantages and features of the inventions have been described herein. It is to be understood that not necessarily any or all such advantages are achieved in accordance with any particular embodiment of the inventions disclosed herein. No aspects of this disclosure are essential or indispensable.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of an intervertebral implant in an unexpanded state while positioned intermediate adjacent vertebrae, according to an embodiment.



FIG. 2 is a side view of the intervertebral implant shown in FIG. 1 in an expanded state.



FIG. 3 is a perspective view of the intervertebral implant shown in FIG. 1 in an unexpanded state.



FIG. 4 is a perspective view of the intervertebral implant shown in FIG. 1 in an expanded state.



FIG. 5 is a side cross sectional view of the intervertebral implant shown in FIG. 3 in an unexpanded state, the cross sectional view is taken along line 5-5 of FIG. 3.



FIG. 6 is a side cross sectional view of the intervertebral implant shown in FIG. 3 in an unexpanded state, the cross sectional view is taken along line 6-6 of FIG. 3.



FIG. 7 is a side cross-sectional view of the intervertebral implant shown in FIG. 4 in an expanded state, the cross-sectional view is taken along line 7-7 of FIG. 4.



FIG. 8 is a side cross-sectional view of the intervertebral implant shown in FIG. 4 in an expanded state, the cross-sectional view is taken along line 8-8 of FIG. 4.



FIG. 9 is a bottom view of the intervertebral implant shown in FIG. 1 in an unexpanded state.



FIG. 10 is a side view of the intervertebral implant shown in FIG. 1 in an expanded state.



FIG. 11 is a front cross-sectional view of the intervertebral implant shown in FIG. 10 taken along lines 11-11.



FIG. 12 is a top perspective view of an upper body portion of the intervertebral implant shown in FIG. 1.



FIG. 13 is a bottom perspective view of the upper body portion of the intervertebral implant shown in FIG. 1.



FIG. 14 is a perspective view of an actuator shaft of the intervertebral implant shown in FIG. 1.



FIG. 15 is a front perspective view of a proximal wedge member of the intervertebral implant shown in FIG. 1.



FIG. 16 is a rear perspective view of the proximal wedge member of the intervertebral implant shown in FIG. 1.



FIG. 17 is a front perspective view of a distal wedge member of the intervertebral implant shown in FIG. 1.



FIG. 18 is a rear perspective view of the distal wedge member of the intervertebral implant shown in FIG. 1.



FIG. 19A illustrates a perspective view of a linkage of the intervertebral implant shown in FIG. 1.



FIG. 19B illustrates a side view of the linkage illustrated in FIG. 19A.



FIG. 19C illustrates a top view of the linkage illustrated in FIG. 19A.



FIG. 20 is a perspective view of a long pin of the intervertebral implant shown in FIG. 1.



FIG. 21 is a perspective view of a short pin of the intervertebral implant shown in FIG. 1.





DETAILED DESCRIPTION

In accordance with certain embodiments disclosed herein, an improved intervertebral implant is provided that allows the clinician to insert the intervertebral implant through a minimally invasive procedure. For example, one or more intervertebral implants can be inserted percutaneously to reduce trauma to the patient and thereby enhance recovery and improve overall results of the surgery.


An intervertebral implant can include a plurality of body sections that are selectively separable and expandable upon contraction of a centrally disposed actuator. The actuator can be utilized to contract against faces of the body sections to cause the expansion thereof. The implant can also be configured such that the actuator provides for both the expansion and contraction of the body sections. The actuator can comprise an interaction between the body sections and another element, an action performed by another element, or a combination of interactions between various elements of the implant and its body sections. Further, the implant can be configured to allow either rough or fine incremental adjustments in the expansion of the implant.


The embodiments disclosed herein are discussed in the context of an intervertebral implant and spinal fusion because of the applicability and usefulness in such a field. As such, various embodiments can be used to properly space adjacent vertebrae in situations where a disc has ruptured or otherwise been damaged. As also disclosed herein, embodiments can also be used as vertebral body replacements. Thus, “adjacent” vertebrae can include those originally separated only by a disc or those that are separated by intermediate vertebra and discs. Such embodiments can therefore tend to recreate proper disc height and spinal curvature as required in order to restore normal anatomical locations and distances. However, it is contemplated that the teachings and embodiments disclosed herein can be beneficially implemented in a variety of other operational settings, for spinal surgery and otherwise.


For example, the implant disclosed herein can also be used as a vertebral body replacement. In such a use, the implant could be used as a replacement for a lumbar vertebra, such as one of the L1-L5 vertebrae. Thus, the implant could be appropriately sized and configured to be used intermediate adjacent vertebrae, or to entirely replace a damaged vertebra.


It is contemplated that the implant can be used as an interbody or intervertebral device or can be used to replace a vertebral body entirely. The implant can also be used in vertebral body compression fractures. Further, the implant can be used as a tool to expand an intervertebral space or bone in order to fill the space or bone with a cement; in such cases, the implant can be removed or left in once the cement is placed. Furthermore, the implant can also be used as a tool to pre-dilate the disc space. In some embodiments, the implant can be removed once the disc space is dilated, and a different implant (expandable or non-expandable) can then be implanted in the dilated disc space. The implant can also be introduced into the disc space anteriorly in an anterior lumbar interbody fusion (ALIF) procedure, posterior in an posterior lumbar interbody fusion (PILF) or posterior lateral interbody fusion, from extreme lateral position in an extreme lateral interbody fusion procedure (XLIF) or direct lateral interbody fusion (DLIF), from a far lateral position in a transforaminal lumbar interbody fusion (TLIF), to name a few. In other arrangements, the implant can be inserted through the Kambin triangle or be inserted through the Kambin triangle after the Kambin triangle has been enlarged via removing bone (e.g., techniques such as PerX360® System™ sold by Intervention Spine®). Although the implant is primarily described herein as being used to expand in a vertical direction, it can also be implanted to expand in a horizontal direction in order to increase stability and/or increase surface area between adjacent vertebral bodies.


Therefore, it is contemplated that a number of advantages can be realized utilizing various embodiments disclosed herein. For example, as will be apparent from the disclosure, no external distraction of the spine is necessary. Further, no distraction device is required in order to install various embodiments disclosed herein. In this regard, embodiments of the implant can enable sufficient distraction of adjacent vertebra in order to properly restore disc height or to use the implant as a vertebral body replacement. Thus, normal anatomical locations, positions, and distances can be restored and preserved utilizing many of the embodiments disclosed herein.


Referring to FIG. 1, there is illustrated a side view of an embodiment of a intervertebral implant 200 in an unexpanded state while positioned generally between adjacent vertebrae of the lumbar portion of the spine 212. FIG. 2 illustrates the intervertebral implant 200 in an expanded state, thereby supporting the vertebrae in a desired orientation and spacing in preparation for spinal fusion. As is known in the art, spinal fusion is the process by which the adjacent vertebrae of the spine are united together (“fused”) so that motion no longer occurs between the vertebrae. Thus, the intervertebral implant 200 can be used to provide the proper spacing two vertebrae to each other pending the healing of a fusion. See also U.S. Pat. No. 7,824,429, filed Jul. 18, 2003, the entirety of the disclosure of which is hereby incorporated by reference.


In certain embodiment, the implant can be installed in an operation that generally entails the following procedures. The damaged disc or vertebra can be decompressed, such as by distracting. The subject portion (or entire) disc or vertebra can then be removed. The adjacent vertebrae can be prepared by scraping the exposed adjacent portion or plates thereof (typically to facilitate bleeding and circulation in the area). Typically, most of the nucleus of the disc is removed and the annulus of the disc is thinned out. Although individual circumstances may vary, it may be unusual to remove all of the annulus or to perform a complete diskectomy. The implant can then be installed. In some embodiments, distraction of the disc may not be a separate step from placement of the implant; thus, distraction can be accomplished and can occur during placement of the implant. Finally, after implantation of the implant, osteogenic substances, such as autogenous bone graft, bone allograft, autograft foam, or bone morphogenic protein (BMP) can be strategically implanted adjacent the implant to prompt bone in-growth in the intervertebral space. In this regard, as the implant is expanded, the spaces within the implant can be backfilled; otherwise, the implant can be pre-packed with biologics.


The intervertebral implant is often used in combination with posterior and/or anterior fixation devices (e.g., rods, plates, screws, etc. that span two or more vertebrae) to limit movement during the fusion process. U.S. Pat. No. 7,824,429 discloses a particularly advantageous posterior fixation device and method which secures two adjacent vertebra to each other in a trans-laminar, trans-facet or facet-pedicle (e.g., the Boucher technique) application using fixation screws.


It should also be appreciated that in FIGS. 1 and 2 only one intervertebral implant 200 is shown positioned between the vertebrae 212. However, two, three, or more implants 200 can be inserted into the space between the vertebrae 212. Further, other devices, such as bone screws, can be used on the vertebrae as desired. For example, in a spinal fusion procedure, it is contemplated that one or more implants 200 can be used in conjunction with one or more bone screws and/or dynamic stabilization devices, such as those disclosed in the above-mentioned U.S. Pat. No. 7,824,429, filed Jul. 18, 2003.


In certain embodiments, the implant 200 can be used in combination with a dynamic stabilization devices such as those disclosed in U.S. Pat. No. 7,648,523, filed Feb. 11, 2005; U.S. Pat. No. 6,951,561, filed on May 6, 2004; U.S. Pat. No. 7,998,176, filed on Jun. 6, 2008; and U.S. Pat. No. 7,824,429, filed Jul. 18, 2003; the entireties of the disclosures of which are hereby incorporated by reference. In this manner, the implant 200 can be used to maintain height between vertebral bodies while the dynamic stabilization device provides limits in one or more degrees of movement.



FIG. 3 is a perspective view of an intervertebral implant 200 in an unexpanded state, and FIGS. 5 and 6 illustrate cross-sections of the intervertebral implant 200 in the unexpanded state. The implant 200 can comprise upper and lower body portions 202, 204, proximal and distal wedge members 206, 208, first and second linkages 254, 265, and an actuator shaft 210. In the unexpanded state, the upper and lower body portions 202, 204 can be generally abutting with a height of the implant 200 being minimized. However, the implant 200 can be expanded, as shown in FIG. 4, to increase the height of the implant 200 when implanted into the intervertebral space of the spine. FIGS. 7 and 8 illustrate cross-sections of the intervertebral implant 200 in the expanded state.


It is contemplated that the actuator shaft 210 can be rotated to cause the proximal and distal wedge members to move toward each other, thus causing the upper and lower body portions 202, 204 to be separated. In some embodiments, the implant 200 can include one or more linkages configured to connect the upper and lower body portions 202, 204 when the implant 200 is in an expanded state. For example, as shown in FIGS. 3 and 4, the implant 200 can include first and second linkages 254, 265. The linkages 254, 265 can be configured to move between a first configuration (shown in FIG. 5) and a second configuration (shown in FIG. 7).


Each of the intervertebral implant components will be described in further detail below in reference to FIGS. 9-21.


In some embodiments, the height of the implant 200 can be or vary within a range from at least about 6 mm to less than or equal to about 15 mm, and more preferably, from about 6.5 mm to about 12 mm. The width of the implant can be at least about 7 mm and/or less than or equal to about 18 mm, and preferably approximately 9 mm or 18 mm. Thus, the implant 200 can have a preferred aspect ratio of between approximately 6:18 and 15:7, and preferably approximately between 6.5:9 and 12:9, or between 6.5:18 and 12:18.


The length of the implant 200 can be or vary within a range from at least 18 mm to less than or equal to about 54 mm. In certain aspects, the length of the implant 200 can be or vary within a range from least about 18 mm to less than or equal to about 35 mm, and preferably from about 25 mm to about 31 mm. In certain aspects, the length of the implant 200 can be or vary within a range from least about 45 mm to less than or equal to about 54 mm. In some embodiments, the implant can have a greater length in the unexpanded state than in the expanded state. It is contemplated that various modifications to the dimension disclosed herein can be made by one of skill and the mentioned dimensions shall not be construed as limiting.


The intervertebral implant components can be manufactured in accordance with any of a variety of techniques which are well known in the art, using any of a variety of medical-grade construction materials. For example, the upper and lower body portions 202, 204, the actuator shaft 210, and other components can be injection-molded from a variety of medical-grade polymers including high or other density polyethylene, PEEK™ polymers, nylon and polypropylene.


The intervertebral implant 200 components can be molded, formed or machined from biocompatible metals such as Nitinol, stainless steel, titanium, and others known in the art. Non-metal materials such as plastics, PEEK™ polymers, and rubbers can also be used. Further, the implant components can be made of combinations of PEEK™ polymers and metals. In some embodiments, the intervertebral implant components can be injection-molded from a bioabsorbable material, to eliminate the need for a post-healing removal step.


The intervertebral implant components may be coated with or contain one or more bioactive substances, such as antibiotics, chemotherapeutic substances, angiogenic growth factors, substances for accelerating the healing of the wound, growth hormones, anti-thrombogenic agents, bone growth accelerators or agents, and the like. Such bioactive implants may be desirable because they contribute to the healing of the injury in addition to providing mechanical support. For example, in some embodiments, the upper and lower body portions 202, 204 can be coated with a bio-active coating, including, but not limited, to a hydroxyapatite coating, a titanium plasma spray, a resorbable blast media coating, or composite coatings. The upper and lower body portions 202, 204 can be coated after the implant is fully assembled, such that other components exposed along the upper and lower surfaces of the implant can also be coated with hydroxyapatite.


In some embodiments, the intervertebral implant components can be surface treated to increase the strength of the components. For example, the intervertebral implant components can be sand blasted, shot peened, laser peened, or otherwise treated to increase strength.


In addition, the intervertebral implant components may be provided with any of a variety of structural modifications to accomplish various objectives, such as osteoincorporation, or more rapid or uniform absorption into the body. For example, osteoincorporation may be enhanced by providing a micropitted or otherwise textured surface on the intervertebral implant components. Alternatively, capillary pathways may be provided throughout the intervertebral implant, such as by manufacturing the intervertebral implant components from an open cell foam material, which produces tortuous pathways through the device. This construction increases the surface area of the device which is exposed to body fluids, thereby generally increasing the absorption rate. Capillary pathways may alternatively be provided by laser drilling or other technique, which will be understood by those of skill in the art in view of the disclosure herein. Additionally, apertures can be provided in the implant to facilitate packing of biologics into the implant, backfilling, and/or osseointegration of the implant. In general, the extent to which the intervertebral implant can be permeated by capillary pathways or open cell foam passageways may be determined by balancing the desired structural integrity of the device with the desired reabsorption time, taking into account the particular strength and absorption characteristics of the desired polymer.


The implant 200 can be at least partially radiolucent, which radiolucency can allow a doctor to perceive the degree of bone growth around and through the implant. The individual components of the implant 200 can be fabricated of such materials based on needed structural, biological and optical properties.


The intervertebral implant may be sterilized by any of the well-known sterilization techniques, depending on the type of material. Suitable sterilization techniques include heat sterilization, ultrasonic sterilization, radiation sterilization, such as cobalt irradiation or electron beams, ethylene oxide sterilization, and the like.



FIG. 9 is a bottom view of the implant 200 shown in FIG. 3. As shown therein, each of the upper and lower body portions 202, 204 can also include one or more openings 274, 276 for receiving the first and second linkages 254, 265 and/or receiving graft material or other bioactive substances. The openings 274, 276 can be disposed on either side of a central receptacle 298 (FIG. 13).


In some embodiments, the two openings 274, 276 can be similarly shaped. For example, as shown in FIG. 9, each opening 274, 276 can include a first elongate portion having a width and a second portion having a width greater than the first elongate portion width. As shown in FIG. 9, at least a part of the actuator shaft 210 is visible through the second portion of each opening 274, 276. The second opening 276 can be disposed at a 180 degree angle from the first opening 274 and/or horizontally displaced from the first opening 274.


In certain variants, the openings 274, 276 can be single elongate portions through which the first and second linkages 254, 265 extend. Although not shown in the FIGS., the upper and lower body portions 202, 204 can include additional openings for receiving graft material or other bioactive substances. Each of the openings can be shaped similarly or differently. The additional openings can be vertically and/or horizontally displaced from each other along the upper and body portions 202, 204. The additional opens can be aligned with a longitudinal axis of the implant 200 or positioned off-center. One or more of the openings can be generally rounded, including, but not limited to, a generally elliptical shape, or include a light-bulb shape. The width of one or more of the openings can vary across a length of the opening.


In some embodiments, the implant 200 can comprise one or more protrusions 260 on a bottom surface 262 of the lower body portion 204. As shown in FIG. 12, the upper body portion 204 can also define a top surface having one or more protrusions 260 thereon. The protrusions 260 can allow the implant 200 to engage the adjacent vertebrae when the implant 200 is expanded to ensure that the implant 200 maintains a desired position in the intervertebral space.


The protrusions 260 can be configured in various patterns. As shown, the protrusions 260 can be formed from grooves extending widthwise along the bottom surface 262 of the implant 200 (also shown extending from a top surface 264 of the upper body portion 202 of the implant 200). The protrusions 260 can become increasingly narrow and pointed toward their apex. However, it is contemplated that the protrusions 260 can be one or more raised points, cross-wise ridges, or the like.


In FIG. 9, the implant 200 is illustrated in the unexpanded state with each of the respective slots 222 of the lower body portion 204 and lower guide members 270, 272 of the respective ones of the proximal and distal wedge members 206, 208. In some embodiments, as shown in FIGS. 12-13, the slots and guide members can be configured to incorporate a generally dovetail shape. Thus, once a given guide member is slid into engagement with a slot, the guide member can only slide longitudinally within the slot and not vertically from the slot. This arrangement can ensure that the proximal and distal wedge members 206, 208 are securely engaged with the upper and lower body portions 202, 204.


In FIG. 10, a side view of the embodiment of the implant 200 in the expanded state illustrates the angular relationship of the proximal and distal wedge members 206, 208 and the upper and lower body portions 202, 204. As mentioned above, the dovetail shape of the slots and guide members ensures that for each given slot and guide member, a given wedge member is generally interlocked with the give slot to only provide one degree of freedom of movement of the guide member, and thus the wedge member, in the longitudinal direction of the given slot.


Accordingly, in such an embodiment, the wedge members 206, 208 may not be separable from the implant when the implant 200 is in the unexpanded state (as shown in FIG. 3) due to the geometric constraints of the angular orientation of the slots and guide members with the actuator shaft inhibiting longitudinal relative movement of the wedge members 206, 208 relative to the upper and lower body portions 202, 204. Such a configuration ensures that the implant 200 is stable and structurally sound when in the unexpanded state or during expansion thereof, thus facilitating insertion and deployment of the implant 200.


Such an embodiment of the implant 200 can therefore be assembled by placing or engaging the wedge members 206, 208 with the actuator shaft 210, moving the wedge members 206, 208 axially together, and inserting the upper guide members 230, 232 into the slots 220 of the upper body portion 202 and the lower guide members 270, 272 into the slots 222 of the lower body portion 204. The wedge members 206, 208 can then be moved apart, which movement can cause the guide members and slots to engage and bring the upper and lower body portions toward each other. The implant 200 can then be prepared for insertion and deployment by reducing the implant 200 to the unexpanded state.


Referring again to FIG. 10, the implant 200 can define generally convex top and bottom surfaces 264, 262. This shape can be configured to generally match the concavity of adjacent vertebral bodies.



FIGS. 12-13 illustrate perspective views of the upper body portion 202 of the implant 200, according to an embodiment. These FIGS. provide additional clarity as to the configuration of the slots 220 and illustrate a first and second side portions 240, 242 of the upper body portion 202. The upper and lower body portions 202, 204 can also define a central receptacle 298 wherein the actuator shaft can be received, and two openings 274, 276 for receiving the first and second linkages 254, 265. Although the FIGS. illustrate the actuator shaft 210 disposed along a central receptacle 298 of the upper and lower body portions 202, 204, in certain variants, the actuator shaft 210 can be disposed off-center. This may be useful to provide a continuous graft channel along a central portion of the implant, from the top surface of the implant to the bottom surface of the implant.


It is contemplated that some embodiments of the implant 200 can be configured such that the upper and lower body portions 202, 204 each include side portions (shown as first side portion 240 and second side portion 242 of the upper body portion 202) to facilitate the alignment, interconnection, and stability of the components of the implant 200. The first and second side portions 240, 242 can be configured to have complementary structures that enable the upper and lower body portions 202, 204 to move in a vertical direction an maintain alignment in a horizontal direction. For example, as shown in FIGS. 12-13, the first side portion 240 can include an extending portion and the second side portion 242 can include a receiving portion for receiving the extending portion of the first side portion 240. As shown in FIG. 10, the first and second side portions 240, 242 of the upper body portion 202 can be configured to disengage from the first and second side portions 240, 242 of the lower body portion 202 when the implant 200 is in the expanded state.



FIG. 9 illustrates a bottom view of the profile of an embodiment of the first side portion 240 and the second side portion 242. As shown in FIG. 9, having a pair of each of first and second side portions 240, 242 can ensure that the upper and lower body portions 202, 204 do not translate relative to each other, thus further ensuring the stability of the implant 200.


In some embodiments, the implant 200 can be configured to include one or more apertures 252 to facilitate osseointegration of the implant 200 within the intervertebral space. As mentioned above, the implant 200 may contain one or more bioactive substances, such as antibiotics, chemotherapeutic substances, angiogenic growth factors, substances for accelerating the healing of the wound, growth hormones, anti-thrombogenic agents, bone growth accelerators or agents, and the like. Indeed, various biologics can be used with the implant 200 and can be inserted into the disc space or inserted along with the implant 200. The apertures 252 can facilitate circulation and bone growth throughout the intervertebral space and through the implant 200. In such implementations, the apertures 252 can thereby allow bone growth through the implant 200 and integration of the implant 200 with the surrounding materials.


As shown in FIG. 14, the actuator shaft 210 can have at least one thread 294 disposed along at least a portion thereof, if not along the entire length thereof. The actuator shaft 210 can be threadably and/or freely attached to one or both of the proximal and distal wedge members 206, 208. The actuator shaft 210 can also be configured such that a proximal portion of the actuator shaft 210 can be removed after the implant 200 has been expanded in order to eliminate any proximal protrusion of the actuator shaft 210. Although, the present embodiment is illustrated using this mode of expansion, it is contemplated that other modes of expansion (e.g., one way-ratchet type mechanism) can be combined with or interchanged herewith.


The threads can be configured to be left hand threads at a distal end of the actuator shaft 210 and right hand threads at a proximal other end of the actuator shaft 210 for engaging the respective ones of the distal and proximal wedge members 208, 206. Accordingly, upon rotation of the actuator shaft 210, the wedge members 206, 208 can be caused to move toward or away from each other to facilitate expansion or contraction of the implant 200.


In some embodiments, the actuator shaft 210 can facilitate expansion of the implant 200 through rotation, longitudinal contract of the pin, or other mechanisms. The actuator shaft 210 can include threads that threadably engage at least one of the proximal and distal wedge members 206, 208. The actuator shaft 210 can also facilitate expansion through longitudinal contraction of the actuator shaft as proximal and distal collars disposed on inner and outer sleeves move closer to each other to in turn move the proximal and distal wedge members closer together. It is contemplated that in certain variants, at least a portion of the actuator shaft can be axially fixed relative to one of the proximal and distal wedge members 206, 208 with the actuator shaft being operative to move the other one of the proximal and distal wedge members 206, 208 via rotational movement or longitudinal contraction of the pin.


In some embodiments, wherein the actuator shaft 210 is threaded, it is contemplated that the actuator shaft 210 can be configured to bring the proximal and distal wedge members closer together at different rates. In such embodiments, the implant 200 could be expanded to a V-configuration or wedged shape. For example, the actuator shaft 210 can comprise a variable pitch thread that causes longitudinal advancement of the distal and proximal wedge members at different rates. The advancement of one of the wedge members at a faster rate than the other could cause one end of the implant to expand more rapidly and therefore have a different height that the other end. Such a configuration can be advantageous depending on the intervertebral geometry and circumstantial needs.


The actuator shaft 210 can be utilized to provide a stabilizing axial force to the proximal and distal wedge members 206, 208 in order to maintain the expansion of the implant 200. However, it is also contemplated that other features can be incorporated into such an embodiment to facilitate the maintenance of the expansion. In this regard, although the axial force provided by the actuator shaft 210 can tend to maintain the position and stability of the proximal and distal wedge members 206, 208, additional features can be employed to ensure the strength and stability of the implant 200 when in its expanded state. For example, the proximal and distal wedge members 206, 208 can include ribbed engagement surfaces (not shown). The use of the ribbed engagement surfaces can permit one-way, ratchet type longitudinal movement of proximal and distal wedge members 206, 208 relative to the upper and lower body portions 202, 204 in order to maintain the upper and lower body portions at a given separation distance. Various other features that can be used to facilitate the expansion of two body portions of an intervertebral implant are disclosed in U.S. Pat. No. 8,105,382, filed Dec. 7, 2007, the entirety of which is hereby incorporated by reference.


The actuator shaft 210 can be cannulated and/or include one or more apertures. The one or more apertures and/or cannula can provide access to an internal portion of the implant, so bone graft or other bioactive materials described herein can be directly injected into the implant to promote fusion.


In accordance with an embodiment, the actuator shaft 210 can also comprise a tool engagement section 296. The tool engagement section 296 can be configured as a to be engaged by a tool 400. The tool engagement section 296 can be shaped as a polygon, such as a hex shape to facilitate the transfer of torque to the actuator shaft 210 from the tool 400. For example, the tool 400 can include a distal engagement member 430 being configured to engage a proximal end of the actuator shaft 210 of the implant 200 for rotating the actuator shaft 210 to thereby expand the implant from an unexpanded state to and expanded state.


The proximal end of the actuator shaft can also include a number of tool engagement features configured to engage with a number of corresponding engagement features at a distal end of the tool 400 (shown in FIG. 4). These tool engagement features can be configured to increase torque strength and facilitate rotation of the actuator shaft. As shown in FIG. 14, the tool engagement features can take the form of one or more grooves or indentations. The number of tool engagement features can equal the number of faces on the tool engagement section. For example, the actuator shaft 210 can include six tool engagement features. The tool engagement features can be disposed at a proximal end of the actuator shaft 210, between the threaded portion 294 and the tool engagement section 296. In certain aspects, the tool engagement features can surround a base of the tool engagement section 296. FIG. 4 illustrates the corresponding engagement features of the tool 400. The corresponding features can take the form of protrusions, nubs, fingers, or otherwise, at the distal end of the tool 400.



FIG. 15-16 illustrate perspective views of the proximal wedge member 206 of the implant 200. The proximal wedge member 206 can include one or more anti-torque structures 250. Further, the guide members 230, 270 are also illustrated. The proximal wedge member 206 can comprise a central aperture 300 wherethrough an actuator shaft can be received. When actuator shaft 210 is used in an embodiment, the central aperture 300 can be threaded to correspond to the threads 294 of the actuator shaft 210. In other embodiments, the actuator shaft can engage other portions of the wedge member 206 for causing expansion or contraction thereof.


In some embodiments, the implant 200 can be configured such that the proximal and distal wedge members 206, 208 are interlinked with the upper and lower body portions 202, 204 to improve the stability and alignment of the implant 200. For example, the upper and lower body portions 202, 204 can be configured to include slots (slot 220 is shown in FIG. 3, and slots 220, 222 are shown in FIG. 4). The proximal and distal wedge members 206, 208 can be configured to include at least one guide member (an upper guide member 230 of the proximal wedge member 206 is shown in FIGS. 15-16 and an upper guide member 232 of the distal wedge member 208 is shown in FIGS. 17-18) that at least partially extends into a respective slot 220, 222 of the upper and lower body portions 202, 204. The arrangement of the slots and the guide members can enhance the structural stability and alignment of the implant 200.


In some embodiments, the implant 200 can be configured to include anti-torque structures 250. The anti-torque structures 250 can interact with at least a portion of a deployment tool during deployment of the implant to ensure that the implant maintains its desired orientation. For example, when the implant 200 is being deployed and a rotational force is exerted on the actuator shaft 210, the anti-torque structures 250 can be engaged by a non-rotating structure of the deployment tool to maintain the rotational orientation of the implant 200 while the actuator shaft 210 is rotated. The anti-torque structures 250 can comprise one or more inwardly extending holes or indentations on the proximal wedge member 206, which are shown as a pair of holes in FIGS. 3-4. However, the anti-torque structures 250 can also comprise one or more outwardly extending structures.


The tool 400 can also include an anti-torque component to engage one or more anti-torque structures 250 of the implant 200. The anti-torque component can include one or more protrusions that engage the anti-torque structures 250 to prevent movement of the implant 200 when a rotational force is applied to the actuator shaft 210 via the tool 400. Other deployment methods can also be used, such as those disclosed in U.S. Pat. No. 8,105,382.



FIG. 17-18 illustrate perspective views of the distal wedge member 208 of the implant 200. As similarly discussed above with respect to the proximal wedge member 206, the guide members 232, 272 and a central aperture 302 of the proximal wedge member 206 are illustrated. The central aperture 302 can be configured to receive an actuator shaft therethrough. When actuator shaft 210 is used in an embodiment, the central aperture 302 can be threaded to correspond to the threads 294 of the actuator shaft 210. In other embodiments, the actuator shaft can engage other portions of the wedge member 208 for causing expansion or contraction thereof.


As shown in FIGS. 19A-19C, each linkage 254, 265 can have a width W and a length L. The length L can be substantially longer than the width W. In some embodiments, the length L can be at least two times the width W, at least three times the W, or otherwise. Each linkage 254, 265 can include one or more cam paths 282, 284 through which a long pin 258 (FIG. 20) or a short pin 263 (FIG. 21) can move. Each linkage can also include shaft portions 278, 286. The axis extending through the shaft portions 278, 286 can be substantially transverse to the longitudinal axis of the linkages 254, 265. Shaft portion 278 can be longer than shaft portion 286.


The linkages can be positioned such that the longer shaft portion 278 can engage the side portions 240, 242 of the upper and lower body portions 202, 204. For example, each of the side portions 240, 242 can include a receiving portion 293, 295 for receiving the longer shaft portion 278 when the implant 202 is in the unexpanded state. Each of the upper and lower body portions 202, 204 can also include internal receiving portions 297, 299 for receiving the shorter shaft portions 286 when the implant 200 is in the unexpanded state. The receiving portions can be slots, grooves, indentations, or other features capable of receiving the shaft portions 278, 286.


The linkages 254, 265 can facilitate the alignment, interconnection, and stability of the upper and lower body portions 202, 204. As shown in FIG. 4, the long and short pins 258, 263 can connect the linkages 254, 265 to the upper and lower body portions 202, 204. The upper and lower body portions 202, 204 can each include apertures 290, 292 for receiving the pins 258, 263 (shown in FIGS. 12-13). For example, the long pin 258 can extend from the cam path 284 to the side portion aperture 290 disposed on the first side portion 240, and the short pin 263 can extend from the cam path 282 to the to the side portion aperture 292 disposed on the second side portion 242. FIG. 11 illustrates how the upper and lower body portions 202, 204 can connect to linkages 254, 265 via the pins 263. FIG. 11 illustrates a cross-section of FIG. 10 taken along line 11-11.


In addition, the linkages 254, 265 can act as motion limiting structures that limit the separation between the upper and lower body portions 202, 204. As the upper and lower side portions 202, 204 move apart, the pins 258, 263 move along their respective cam paths 282, 284 and force the linkages 254, 265 to rotate from the first configuration to the second configuration. In the first configuration, an axis extending across the width W of each linkage 254, 265 is substantially transverse to a longitudinal axis of the implant 200. In the second configuration, the axis extending across the width W of each linkage 254, 265 is nearly or substantially parallel to the longitudinal axis of the implant 200. The upper and lower body portions 202, 204 can only move apart so far as the linkages 254, 265 will permit. As such, the distance between the upper and lower body portions 202, 204 is limited by the distance between far ends of cam paths 282, 284.


Although not shown in the FIGS., the implant 200 can include additional linkages to provide further stability. Each of the additional linkages can connect to the upper and lower body portions 202, 204 as described above. For example, the additional linkages can be horizontally displaced from the first and second linkages 254, 265 described herein. In certain variants, the additional linkages can connect to the first and second linkages 254, 265 to permit further expansion of the upper and lower body portions 202, 204. For example, the upper and lower body portions 202, 204 can be separated by a distance equivalent to two linkages.


The specific dimensions of any of the embodiment disclosed herein can be readily varied depending upon the intended application, as will be apparent to those of skill in the art in view of the disclosure herein. Moreover, although the present inventions have been described in terms of certain preferred embodiments, other embodiments of the inventions including variations in the number of parts, dimensions, configuration and materials will be apparent to those of skill in the art in view of the disclosure herein. In addition, all features discussed in connection with any one embodiment herein can be readily adapted for use in other embodiments herein to form various combinations and sub-combinations. The use of different terms or reference numerals for similar features in different embodiments does not imply differences other than those which may be expressly set forth. Accordingly, the present inventions are intended to be described solely by reference to the appended claims, and not limited to the preferred embodiments disclosed herein.

Claims
  • 1. An adjustable spinal fusion intervertebral implant comprising: upper and lower body portions each having proximal and distal surfaces at proximal and distal ends thereof, the proximal and distal surfaces of the upper and lower body portions generally facing each other;a proximal wedge member disposed at the proximal ends of the respective ones of the upper and lower body portions;a distal wedge member disposed at the distal ends of the respective ones of the upper and lower body portions;first and second linkages each connected to and rotatable relative to the upper and lower body portions; andan actuator shaft received between the upper and lower body portions, the actuator shaft extending along a first axis, the actuator shaft extending intermediate the distal and proximal wedge members, wherein rotation of the actuator shaft causes the distal and proximal wedge members to be drawn together such that longitudinal movement of the distal wedge member against the distal surfaces and the longitudinal movement of the proximal wedge member against the proximal surfaces causes separation of the upper and lower body portions and rotation of the first linkage and the second linkage about a second axis perpendicular to the first axis,wherein the upper body portion further comprises an upper first side portion and an upper second side portion, each having an upper separation edge closest to the lower body portion, wherein the lower body portion further comprises a lower first side portion and a lower second side portion, each having a lower separation edge closest to the upper body portion, wherein the upper separation edges and the lower separation edges are separated along a third axis, perpendicular to both the first and second axis, when the actuator causes separation of the upper and lower body portions such that the upper first and second side portions do not overlap with the lower first and second side portions when the implant is in an expanded state.
  • 2. The implant of claim 1, wherein the proximal surfaces of the respective ones of the upper and lower body portions each define a proximal slot therein, and distal surfaces of the respective ones of the upper and lower body portions each define a distal slot therein.
  • 3. The implant of claim 2, wherein the slots of the proximal and distal surfaces of the upper and lower body portions are generally dove-tailed.
  • 4. The implant of claim 2, wherein the proximal wedge member and the distal wedge member each comprise upper and lower guide members extending at least partially into the respective ones of the proximal and distal slots of the upper and lower body portions with at least a portion of the proximal wedge member and the distal wedge member contacting the proximal and distal surfaces of the upper and lower body portions.
  • 5. The implant of claim 4, wherein the guide members of the proximal and distal wedge members are generally dovetailed.
  • 6. The implant of claim 1, the upper and lower first side portion further comprising an extending portion and the upper and lower second side portion further comprising a receiving portion, the upper first side portion of the upper body portion configured to mate with the lower second side portion of the lower body portion and the upper second side portion of the upper body portion configured to mate with the lower first side portion of the lower body portion.
  • 7. The implant of claim 6, wherein the upper first and second side portions of the upper body portion are configured to disengage from the lower first and second side portions of the lower body portion when the implant is in an expanded state.
  • 8. The implant of claim 1, wherein the proximal and distal surfaces of the upper and lower body portions are sloped.
  • 9. The implant of claim 1, wherein the upper and lower body portions comprise generally arcuate respective upper and lower exterior engagement surfaces.
  • 10. The implant of claim 1, wherein the proximal wedge member comprises an anti-rotational element, the anti-rotational engagement being configured to be engaged by an implant tool for preventing rotation of the implant when the actuator shaft is rotated relative to the implant.
  • 11. The implant of claim 10, wherein the anti-rotational element comprises a pair of apertures extending into the proximal wedge member.
  • 12. The implant of claim 1, wherein the each of the first and second linkages include at least one cam path.
  • 13. The implant of claim 12, wherein a pin is configured to engage a cam path of the at least one cam path to and one of the upper and lower body portions.
  • 14. The implant of claim 1, wherein a length of the implant varies from about 45 mm to about 54 mm during the separation of the upper and lower body portions.
  • 15. The implant of claim 1, wherein a length of the implant varies from about 21 mm to about 31 mm during the separation of the upper and lower body portions.
  • 16. The implant of claim 1, wherein a height of the implant varies from about 6.5 mm to about 12 mm during the separation of the upper and lower body portions.
  • 17. The implant of claim 1, wherein the upper and lower body portions are coated with a bio-active coating.
  • 18. The implant of claim 17, wherein the bio-active coating is a hydroxyapatite coating.
  • 19. The implant of claim 1, wherein each linkage includes two cam path and each of the upper first side portion, the upper second side portion, the lower first side portion, the and lower second side portion comprise a cam configured to rotate along a cam path.
  • 20. The implant of claim 19, wherein the separation distance between the upper and lower body portions is limited by the distance between far ends of cam paths.
US Referenced Citations (861)
Number Name Date Kind
1802560 Kerwin Apr 1923 A
2077804 Morrison Apr 1937 A
2121193 Hanicke Jun 1938 A
2243717 Moreira May 1941 A
2388056 Hendricks Jul 1943 A
2381050 Hardinge Aug 1945 A
2485531 Dzus et al. Oct 1949 A
2489870 Dzus Nov 1949 A
2570465 Lundholm Oct 1951 A
2677369 Knowles May 1954 A
3115804 Johnson Dec 1963 A
3312139 Di Cristina Apr 1967 A
3486505 Morrison Dec 1969 A
3489143 Holloran Jan 1970 A
3698391 Mahony Oct 1972 A
3760802 Fischer et al. Sep 1973 A
3805775 Fischer et al. Apr 1974 A
3811449 Gravlee et al. May 1974 A
3842825 Wagner Oct 1974 A
3848601 Ma et al. Nov 1974 A
3986504 Avila Oct 1976 A
4013071 Rosenberg Mar 1977 A
4052988 Doddi et al. Oct 1977 A
4091806 Aginsky May 1978 A
4175555 Herbert Nov 1979 A
4236512 Aginsky Dec 1980 A
4262665 Roalstad et al. Apr 1981 A
4275717 Bolesky Jun 1981 A
4312353 Shahbabian Jan 1982 A
4341206 Perrett et al. Jul 1982 A
4350151 Scott Sep 1982 A
4369790 McCarthy Jan 1983 A
4401112 Rezaian Aug 1983 A
4401433 Luther Aug 1983 A
4409974 Freedland Oct 1983 A
4449532 Storz May 1984 A
4451256 Weikl et al. May 1984 A
4456005 Lichty Jun 1984 A
4463753 Gustilo Aug 1984 A
4488543 Tornier Dec 1984 A
4494535 Haig Jan 1985 A
4532660 Field Aug 1985 A
4537185 Stednitz Aug 1985 A
4545374 Jacobson Oct 1985 A
4573448 Kambin Mar 1986 A
4601710 Moll Jul 1986 A
2173655 Himoud Oct 1986 A
4625725 Davison et al. Dec 1986 A
4629450 Suzuki et al. Dec 1986 A
4632101 Freedland Dec 1986 A
4640271 Lower Feb 1987 A
4641640 Griggs Feb 1987 A
4653489 Tronzo Mar 1987 A
4667663 Miyata May 1987 A
4686984 Bonnet Aug 1987 A
4688561 Reese Aug 1987 A
4721103 Freedland Jan 1988 A
4723544 Moore et al. Feb 1988 A
4743257 Tormala et al. May 1988 A
4760843 Fischer et al. Aug 1988 A
4790304 Rosenberg Dec 1988 A
4790817 Luther Dec 1988 A
4796612 Reese Jan 1989 A
4802479 Haber et al. Feb 1989 A
4815909 Simons Mar 1989 A
4827917 Brumfield May 1989 A
4858601 Glisson Aug 1989 A
4862891 Smith Sep 1989 A
4863476 Shepperd Sep 1989 A
4873976 Schreiber Oct 1989 A
4898186 Ikada et al. Feb 1990 A
4903692 Reese Feb 1990 A
4917554 Bronn Apr 1990 A
4940467 Tronzo Jul 1990 A
4959064 Engelhardt Sep 1990 A
4963144 Huene Oct 1990 A
4966587 Baumgart Oct 1990 A
4968317 Tormala et al. Nov 1990 A
4978334 Toye et al. Dec 1990 A
4978349 Frigg Dec 1990 A
4981482 Ichikawa Jan 1991 A
4988351 Paulos et al. Jan 1991 A
4994027 Farrel Feb 1991 A
5002557 Hasson Mar 1991 A
5011484 Breard Apr 1991 A
5013315 Barrows May 1991 A
5013316 Goble et al. May 1991 A
5059193 Kuslich Oct 1991 A
5062849 Schelhas Nov 1991 A
5080662 Paul Jan 1992 A
5084043 Hertzmann et al. Jan 1992 A
5092891 Kummer et al. Mar 1992 A
5098241 Aldridge et al. Mar 1992 A
5098433 Freedland Mar 1992 A
5098435 Stednitz et al. Mar 1992 A
5114407 Burbank May 1992 A
5116336 Frigg May 1992 A
5120171 Lasner Jun 1992 A
5122133 Evans Jun 1992 A
5122141 Simpson et al. Jun 1992 A
5139486 Moss Aug 1992 A
5158543 Lazarus Oct 1992 A
5167663 Brumfield Dec 1992 A
5167664 Hodorek Dec 1992 A
5169400 Muhling et al. Dec 1992 A
5171278 Pisharodi Dec 1992 A
5171279 Mathews Dec 1992 A
5171280 Baumgartner Dec 1992 A
5176651 Allgood et al. Jan 1993 A
5176697 Hasson et al. Jan 1993 A
5178501 Carstairs Jan 1993 A
5183464 Dubrul et al. Feb 1993 A
5188118 Terwilliger Feb 1993 A
5195506 Hulfish Mar 1993 A
5201742 Hasson Apr 1993 A
5217462 Asnis et al. Jun 1993 A
5217486 Rice et al. Jun 1993 A
5224952 Deniega et al. Jul 1993 A
5234431 Keller Aug 1993 A
5241972 Bonati Sep 1993 A
5242410 Melker Sep 1993 A
5242447 Borzone Sep 1993 A
5246441 Ross et al. Sep 1993 A
5250049 Michael Oct 1993 A
5269797 Bonati et al. Dec 1993 A
5280782 Wilk Jan 1994 A
5286001 Rafeld Feb 1994 A
5290243 Chodorow et al. Mar 1994 A
5300074 Frigg Apr 1994 A
5304142 Liebl et al. Apr 1994 A
5308327 Heaven et al. May 1994 A
5308352 Koutrouvelis May 1994 A
5312410 Miller et al. May 1994 A
5312417 Wilk May 1994 A
5324261 Amundson et al. Jun 1994 A
5334184 Bimman Aug 1994 A
5334204 Clewett et al. Aug 1994 A
5342365 Waldman Aug 1994 A
5342382 Brinkerhoff et al. Aug 1994 A
5344252 Kakimoto Sep 1994 A
5364398 Chapman et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370647 Graber et al. Dec 1994 A
5370661 Branch Dec 1994 A
5382248 Jacobson et al. Jan 1995 A
5387213 Breard et al. Feb 1995 A
5387215 Fisher Feb 1995 A
5390683 Pisharodi Feb 1995 A
5395317 Kambin Mar 1995 A
5395371 Miller et al. Mar 1995 A
5407430 Peters Apr 1995 A
5415661 Holmes May 1995 A
5424773 Saito Jun 1995 A
5449359 Groiso Sep 1995 A
5449361 Preissmann Sep 1995 A
5452748 Simmons et al. Sep 1995 A
5454790 Dubrul et al. Oct 1995 A
5464427 Curtis et al. Nov 1995 A
5470333 Ray Nov 1995 A
5472426 Bonati et al. Dec 1995 A
5474539 Costa et al. Dec 1995 A
5486190 Green Jan 1996 A
5496318 Howland et al. Mar 1996 A
5498265 Asnis et al. Mar 1996 A
5501695 Anspach, Jr. et al. Mar 1996 A
5505710 Dorsey, III Apr 1996 A
5512037 Russell et al. Apr 1996 A
5514180 Heggeness et al. May 1996 A
5520690 Errico et al. May 1996 A
5520896 de Graaf et al. May 1996 A
5527312 Ray Jun 1996 A
5536127 Pennig Jul 1996 A
5540688 Navas Jul 1996 A
5540693 Fisher Jul 1996 A
5545164 Howland Aug 1996 A
5549610 Russell et al. Aug 1996 A
5554191 Lahille et al. Sep 1996 A
5558674 Heggeness et al. Sep 1996 A
D374287 Goble et al. Oct 1996 S
5564926 Branemark Oct 1996 A
5569248 Mathews Oct 1996 A
5569251 Baker et al. Oct 1996 A
5569290 McAfee Oct 1996 A
5569548 Koike et al. Oct 1996 A
5591168 Judet et al. Jan 1997 A
5609634 Voydeville Mar 1997 A
5613950 Yoon Mar 1997 A
5618142 Sonden et al. Apr 1997 A
5618314 Harwin et al. Apr 1997 A
5624447 Myers Apr 1997 A
5626613 Schmieding May 1997 A
5628751 Sander et al. May 1997 A
5628752 Asnis et al. May 1997 A
5639276 Weinstock et al. Jun 1997 A
5643320 Lower et al. Jul 1997 A
5645589 Li Jul 1997 A
5645599 Samani Jul 1997 A
5647857 Anderson et al. Jul 1997 A
5649931 Bryant et al. Jul 1997 A
5653763 Errico et al. Aug 1997 A
5658335 Allen Aug 1997 A
5662683 Kay Sep 1997 A
5665095 Jacobson Sep 1997 A
5665122 Kambin Sep 1997 A
5667508 Errico et al. Sep 1997 A
5669915 Caspar et al. Sep 1997 A
5693100 Pisharodi Dec 1997 A
5702391 Lin Dec 1997 A
5707359 Bufalinia Jan 1998 A
5713870 Yoon Feb 1998 A
5713903 Sander et al. Feb 1998 A
5716415 Steffee Feb 1998 A
5716416 Lin Feb 1998 A
5720753 Sander et al. Feb 1998 A
5725541 Anspach, III et al. Mar 1998 A
5725588 Errico et al. Mar 1998 A
5728097 Mathews Mar 1998 A
5728116 Rosenman Mar 1998 A
5735853 Olerud Apr 1998 A
5741282 Anspach, III et al. Apr 1998 A
5743881 Demco Apr 1998 A
5743912 Lahille et al. Apr 1998 A
5743914 Skiba Apr 1998 A
5749889 Bacich et al. May 1998 A
5752969 Cunci et al. May 1998 A
5762500 Lazarof Jun 1998 A
5762629 Kambin Jun 1998 A
5772662 Chapman et al. Jun 1998 A
5772678 Thomason et al. Jun 1998 A
5776156 Shikhman Jul 1998 A
5782800 Yoon Jul 1998 A
5782865 Grptz Jul 1998 A
5792044 Foley et al. Aug 1998 A
5810721 Mueller et al. Sep 1998 A
5810821 Vandewalle Sep 1998 A
5810866 Yoon Sep 1998 A
5814084 Grivas et al. Sep 1998 A
5836948 Zucherman et al. Nov 1998 A
5846259 Berthiaume Dec 1998 A
5849004 Bramlet Dec 1998 A
5851216 Allen Dec 1998 A
5860977 Zucherman et al. Jan 1999 A
5865848 Baker Feb 1999 A
5871485 Rao et al. Feb 1999 A
5873854 Wolvek Feb 1999 A
5876404 Zucherman et al. Mar 1999 A
5888228 Knothe et al. Mar 1999 A
5893850 Cachia Apr 1999 A
5893889 Harrington Apr 1999 A
5895428 Berry Apr 1999 A
5902231 Foley et al. May 1999 A
5904696 Rosenman May 1999 A
5908422 Bresina Jun 1999 A
5928235 Friedl Jul 1999 A
5928244 Tovey et al. Jul 1999 A
5931870 Cuckler et al. Aug 1999 A
5935129 McDevitt et al. Aug 1999 A
5947999 Groiso Sep 1999 A
5948000 Larsen et al. Sep 1999 A
5954722 Bono Sep 1999 A
5954747 Clark Sep 1999 A
5957902 Teves Sep 1999 A
5957924 Tormala et al. Sep 1999 A
5964730 Williams et al. Oct 1999 A
5964761 Kambin Oct 1999 A
5967783 Ura Oct 1999 A
5967970 Cowan et al. Oct 1999 A
5968044 Nicholson et al. Oct 1999 A
5968098 Winslow Oct 1999 A
5976139 Bramlet Nov 1999 A
5976146 Ogawa et al. Nov 1999 A
5976186 Boa et al. Nov 1999 A
5980522 Koros et al. Nov 1999 A
5984927 Wenstrom, Jr. et al. Nov 1999 A
5984966 Kiena et al. Nov 1999 A
5989255 Pepper et al. Nov 1999 A
5993459 Larsen et al. Nov 1999 A
5997510 Schwemberger Dec 1999 A
5997538 Asnis et al. Dec 1999 A
5997541 Schenk Dec 1999 A
6001100 Sherman et al. Dec 1999 A
6001101 Augagneur et al. Dec 1999 A
6004327 Asnis et al. Dec 1999 A
6005161 Brekke et al. Dec 1999 A
6007519 Rosselli Dec 1999 A
6007566 Wenstorm, Jr. Dec 1999 A
6007580 Lehto et al. Dec 1999 A
6010513 Tormala et al. Jan 2000 A
6015410 Tormala et al. Jan 2000 A
6019762 Cole Feb 2000 A
6022352 Vandewalle Feb 2000 A
6030162 Huebner Feb 2000 A
6030364 Durgin et al. Feb 2000 A
6033406 Mathews Mar 2000 A
6036701 Rosenman Mar 2000 A
6048309 Flom et al. Apr 2000 A
6048342 Zucherman et al. Apr 2000 A
6053935 Brenneman et al. Apr 2000 A
6066142 Serbousek et al. May 2000 A
6068630 Zucherman et al. May 2000 A
6068648 Cole et al. May 2000 A
6074390 Zucherman et al. Jun 2000 A
6080193 Hochshuler et al. Jun 2000 A
6083244 Lubbers et al. Jul 2000 A
6090112 Zucherman et al. Jul 2000 A
6102914 Bulstra et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6117174 Nolan Sep 2000 A
6123711 Winters Sep 2000 A
6126661 Faccioli et al. Oct 2000 A
6126663 Hair Oct 2000 A
6129762 Li Oct 2000 A
6129763 Chauvin et al. Oct 2000 A
6146384 Lee et al. Nov 2000 A
6149652 Zucherman et al. Nov 2000 A
6152926 Zucherman et al. Nov 2000 A
6156038 Zucherman et al. Dec 2000 A
6159179 Simonson Dec 2000 A
6161350 Espinosa Dec 2000 A
6162234 Friedland et al. Dec 2000 A
6162236 Osada Dec 2000 A
6168595 Durham et al. Jan 2001 B1
6168597 Biedermann et al. Jan 2001 B1
6175758 Kambin Jan 2001 B1
6176882 Biedermann et al. Jan 2001 B1
6183471 Zucherman et al. Feb 2001 B1
6183472 Lutz Feb 2001 B1
6183474 Bramlet et al. Feb 2001 B1
6190387 Zucherman et al. Feb 2001 B1
6197041 Shichman et al. Mar 2001 B1
6200322 Branch et al. Mar 2001 B1
6206826 Mathews et al. Mar 2001 B1
6206922 Zdeblick et al. Mar 2001 B1
6213957 Milliman et al. Apr 2001 B1
6217509 Foley et al. Apr 2001 B1
6221082 Marino et al. Apr 2001 B1
6228058 Dennis et al. May 2001 B1
6231606 Graf et al. May 2001 B1
6235030 Zucherman et al. May 2001 B1
6238397 Zucherman et al. May 2001 B1
6245107 Ferree Jun 2001 B1
6248108 Tormala et al. Jun 2001 B1
6251111 Barker et al. Jun 2001 B1
6264676 Gellman et al. Jul 2001 B1
6267765 Taylor et al. Jul 2001 B1
6267767 Strobel et al. Jul 2001 B1
6280444 Zucherman et al. Aug 2001 B1
6287313 Sasso Sep 2001 B1
6293909 Chu et al. Sep 2001 B1
6293952 Brosens et al. Sep 2001 B1
6306136 Baccelli Oct 2001 B1
6319254 Giet et al. Nov 2001 B1
6319272 Brenneman et al. Nov 2001 B1
6332882 Zucherman et al. Dec 2001 B1
6332883 Zucherman et al. Dec 2001 B1
6346092 Leschinsky Feb 2002 B1
6348053 Cachia Feb 2002 B1
6355043 Adam Mar 2002 B1
6361537 Anderson Mar 2002 B1
6361538 Fenaroli et al. Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6364897 Bonutti Apr 2002 B1
6368351 Glenn et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6375682 Fleishmann et al. Apr 2002 B1
6379355 Zucherman et al. Apr 2002 B1
6379363 Herrington et al. Apr 2002 B1
6387130 Stone et al. May 2002 B1
6419676 Zucherman et al. Jul 2002 B1
6419677 Zucherman et al. Jul 2002 B2
6419704 Ferree Jul 2002 B1
6423061 Bryant Jul 2002 B1
6423067 Eisermann Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6428541 Boyd et al. Aug 2002 B1
6428556 Chin Aug 2002 B1
6436143 Ross et al. Aug 2002 B1
6440154 Gellman Aug 2002 B2
6440169 Elberg et al. Aug 2002 B1
6443989 Jackson Sep 2002 B1
6447527 Thompson et al. Sep 2002 B1
6447540 Fontaine et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6451019 Zucherman et al. Sep 2002 B1
6451020 Zucherman et al. Sep 2002 B1
6454807 Jackson Sep 2002 B1
6458134 Songer et al. Oct 2002 B1
6468277 Justin et al. Oct 2002 B1
6468309 Lieberman Oct 2002 B1
6468310 Ralph et al. Oct 2002 B1
6471724 Zdeblick et al. Oct 2002 B2
6475226 Belef et al. Nov 2002 B1
6478029 Boyd et al. Nov 2002 B1
6478796 Zucherman et al. Nov 2002 B2
6485491 Farris et al. Nov 2002 B1
6485518 Cornwall et al. Nov 2002 B1
6488693 Gannoe et al. Dec 2002 B2
6491714 Bennett Dec 2002 B1
6494860 Rocamora et al. Dec 2002 B2
6494893 Dubrul et al. Dec 2002 B2
6500178 Zucherman et al. Dec 2002 B2
6506192 Gertzman et al. Jan 2003 B1
6511481 von Hoffmann et al. Jan 2003 B2
6514256 Zucherman et al. Feb 2003 B2
6517543 Berrevoets et al. Feb 2003 B1
6520907 Foley et al. Feb 2003 B1
6527774 Lieberman Mar 2003 B2
6540747 Marino Apr 2003 B1
6544265 Lieberman Apr 2003 B2
6547793 McGuire Apr 2003 B1
6547795 Schneiderman Apr 2003 B2
6551319 Lieberman Apr 2003 B2
6551322 Lieberman Apr 2003 B1
6554831 Rivard et al. Apr 2003 B1
6554852 Oberlander Apr 2003 B1
6558389 Clark et al. May 2003 B2
6562046 Sasso May 2003 B2
6562049 Norlander et al. May 2003 B1
6562074 Gerbec et al. May 2003 B2
6575979 Cragg Jun 2003 B1
6576016 Hochshuler et al. Jun 2003 B1
6579293 Chandran Jun 2003 B1
6582390 Sanderson Jun 2003 B1
6582431 Ray Jun 2003 B1
6582433 Yun Jun 2003 B2
6582437 Dorchak et al. Jun 2003 B2
6582441 He et al. Jun 2003 B1
6582453 Tran et al. Jun 2003 B1
6585730 Foerster Jul 2003 B1
6585740 Schlapfer et al. Jul 2003 B2
6589240 Hinchliffe Jul 2003 B2
6589249 Sater et al. Jul 2003 B2
6592553 Zhang et al. Jul 2003 B2
6595998 Johnson et al. Jul 2003 B2
6596008 Kambin Jul 2003 B1
6599297 Carlsson et al. Jul 2003 B1
6607530 Carl et al. Aug 2003 B1
6610091 Reiley Aug 2003 B1
6613050 Wagner et al. Sep 2003 B1
6616678 Nishtala et al. Sep 2003 B2
6620196 Trieu Sep 2003 B1
6626944 Taylor Sep 2003 B1
6632224 Cachia et al. Oct 2003 B2
6635059 Randall et al. Oct 2003 B2
6635362 Zheng Oct 2003 B2
6648890 Culbert et al. Nov 2003 B2
6648893 Dudasik Nov 2003 B2
6652527 Zucherman et al. Nov 2003 B2
6655962 Kennard Dec 2003 B1
6666891 Boehm, Jr. et al. Dec 2003 B2
6669698 Tromanhauser et al. Dec 2003 B1
6669729 Chin Dec 2003 B2
6673074 Shluzas Jan 2004 B2
6676664 Al-Assir Jan 2004 B1
6679833 Smith et al. Jan 2004 B2
6682535 Hoogland Jan 2004 B2
6685706 Padget et al. Feb 2004 B2
6685742 Jackson Feb 2004 B1
6689152 Balceta et al. Feb 2004 B2
6692499 Tormalaet et al. Feb 2004 B2
6695842 Zucherman et al. Feb 2004 B2
6695851 Zdeblick et al. Feb 2004 B2
6699246 Zucherman et al. Mar 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6712819 Zucherman et al. Mar 2004 B2
6716247 Michelson Apr 2004 B2
6719760 Dorchak et al. Apr 2004 B2
6723096 Dorchak et al. Apr 2004 B1
6723126 Berry Apr 2004 B1
6730126 Boehm, Jr. et al. May 2004 B2
6733534 Sherman May 2004 B2
6733535 Michelson May 2004 B2
6733635 Ozawa et al. May 2004 B1
6740090 Cragg et al. May 2004 B1
6740093 Hoschschuler et al. May 2004 B2
6743166 Berci et al. Jun 2004 B2
6746451 Middleton et al. Jun 2004 B2
6752831 Sybert et al. Jun 2004 B2
6761720 Senegas Jul 2004 B1
6770075 Howland Aug 2004 B2
6773460 Jackson Aug 2004 B2
6790210 Cragg et al. Sep 2004 B1
6793656 Mathews Sep 2004 B1
6796983 Zucherman et al. Sep 2004 B1
6805695 Keith Oct 2004 B2
6808526 Magerl et al. Oct 2004 B1
6808537 Michelson Oct 2004 B2
6821298 Jackson Nov 2004 B1
6830589 Erikson Dec 2004 B2
6835205 Atkinson et al. Dec 2004 B2
6835206 Jackson Dec 2004 B2
6875215 Taras et al. Apr 2005 B2
6887243 Culbert et al. May 2005 B2
6890333 von Hoffmann et al. May 2005 B2
6893466 Trieu May 2005 B2
6902566 Zucherman et al. Jun 2005 B2
6908465 von Hoffman et al. Jun 2005 B2
6916323 Kitchens et al. Jul 2005 B2
6921403 Cragg et al. Jul 2005 B2
6923811 Carl et al. Aug 2005 B1
6929606 Ritland Aug 2005 B2
6936072 Lambrecht et al. Aug 2005 B2
6942668 Padget et al. Sep 2005 B2
6945975 Dalton Sep 2005 B2
6946000 Senegas et al. Sep 2005 B2
6949100 Venturini Sep 2005 B1
6951561 Warren et al. Oct 2005 B2
6972035 Michelson Dec 2005 B2
6997929 Manzi et al. Feb 2006 B2
7004945 Boyd et al. Feb 2006 B2
7018415 McKay Mar 2006 B1
7025746 Tal Apr 2006 B2
7029473 Zucherman et al. Apr 2006 B2
7041107 Pohjonen et al. May 2006 B2
7048736 Robinson et al. May 2006 B2
7060068 Tromanhauser et al. Jun 2006 B2
7063701 Michelson Jun 2006 B2
7063702 Michelson Jun 2006 B2
7066960 Dickman Jun 2006 B1
7066961 Michelson Jun 2006 B2
7070601 Culbert et al. Jul 2006 B2
7074203 Johanson et al. Jul 2006 B1
7087083 Pasquet et al. Aug 2006 B2
7094239 Michelson Aug 2006 B1
7094257 Mujwid et al. Aug 2006 B2
7094258 Lambrecht et al. Aug 2006 B2
7101375 Zucherman et al. Sep 2006 B2
7114501 Johnson et al. Oct 2006 B2
7118572 Bramlet et al. Oct 2006 B2
7118579 Michelson Oct 2006 B2
7118598 Michelson Oct 2006 B2
7128760 Michelson Oct 2006 B2
7153305 Johnson et al. Dec 2006 B2
D536096 Hoogland et al. Jan 2007 S
7163558 Senegas et al. Jan 2007 B2
7172612 Ishikawa Feb 2007 B2
7179294 Eisermann et al. Feb 2007 B2
7201751 Zucherman et al. Apr 2007 B2
7226481 Kuslich Jun 2007 B2
7238204 Couedic et al. Jul 2007 B2
7267683 Sharkey et al. Sep 2007 B2
7282061 Sharkey et al. Oct 2007 B2
7306628 Zucherman et al. Dec 2007 B2
7309357 Kim Dec 2007 B2
7326211 Padget et al. Feb 2008 B2
7335203 Winslow et al. Feb 2008 B2
7361140 Ries et al. Apr 2008 B2
7371238 Soboleski et al. May 2008 B2
7377942 Berry May 2008 B2
7400930 Sharkey et al. Jul 2008 B2
7410501 Michelson Aug 2008 B2
7413576 Sybert et al. Aug 2008 B2
7422594 Zander Sep 2008 B2
7434325 Foley et al. Oct 2008 B2
7445636 Michelson Nov 2008 B2
7445637 Taylor Nov 2008 B2
D584812 Ries Jan 2009 S
7473256 Assell et al. Jan 2009 B2
7473268 Zucherman et al. Jan 2009 B2
7476251 Zucherman et al. Jan 2009 B2
7488326 Elliott Feb 2009 B2
7520888 Trieu Apr 2009 B2
7547317 Cragg Jun 2009 B2
7556629 von Hoffmann et al. Jul 2009 B2
7556651 Humphreys et al. Jul 2009 B2
7588574 Assell et al. Sep 2009 B2
7625378 Foley Dec 2009 B2
7641657 Cragg Jan 2010 B2
7641670 Davison et al. Jan 2010 B2
7647123 Sharkey et al. Jan 2010 B2
7648523 Mirkovic et al. Jan 2010 B2
7670354 Davison et al. Mar 2010 B2
7674273 Davison et al. Mar 2010 B2
7682370 Pagliuca et al. Mar 2010 B2
7691120 Shluzas et al. Apr 2010 B2
7699878 Pavlov et al. Apr 2010 B2
7717944 Foley et al. May 2010 B2
7722530 Davison May 2010 B2
7727263 Cragg Jun 2010 B2
7740633 Assell et al. Jun 2010 B2
7744599 Cragg Jun 2010 B2
7762995 Eversull et al. Jul 2010 B2
7763025 Assell et al. Jul 2010 B2
7763055 Foley Jul 2010 B2
7766930 DiPoto et al. Aug 2010 B2
7771479 Humphreys et al. Aug 2010 B2
7794463 Cragg Sep 2010 B2
7799032 Assell et al. Sep 2010 B2
7799033 Assell et al. Sep 2010 B2
7799036 Davison et al. Sep 2010 B2
D626233 Cipoletti et al. Oct 2010 S
7814429 Buffet et al. Oct 2010 B2
7819921 Grotz Oct 2010 B2
7824410 Simonson et al. Nov 2010 B2
7824429 Culbert et al. Nov 2010 B2
7837734 Flynn Nov 2010 B2
7846183 Blain Dec 2010 B2
7850695 Pagliuca et al. Dec 2010 B2
7850733 Baynham Dec 2010 B2
7857832 Culbert et al. Dec 2010 B2
7862590 Lim et al. Jan 2011 B2
7862595 Foley et al. Jan 2011 B2
7867259 Foley et al. Jan 2011 B2
7875077 Humphreys et al. Jan 2011 B2
7892171 Davison et al. Feb 2011 B2
7892249 Davison et al. Feb 2011 B2
7901438 Culbert et al. Mar 2011 B2
7901459 Hodges et al. Mar 2011 B2
7931689 Hochschuler et al. Apr 2011 B2
7938832 Culbert et al. May 2011 B2
7998176 Culbert Aug 2011 B2
8062375 Glerum Nov 2011 B2
8105382 Olmos Jan 2012 B2
8109977 Culbert et al. Feb 2012 B2
8133232 Levy Mar 2012 B2
8262736 Michelson Sep 2012 B2
8273129 Baynham Sep 2012 B2
8317866 Palmatier Nov 2012 B2
8366777 Matthis Feb 2013 B2
8394129 Lopez et al. Mar 2013 B2
8398713 Weiman Mar 2013 B2
8926704 Glerum et al. Jan 2015 B2
20010012950 Nishtala et al. Aug 2001 A1
20010027320 Sasso Oct 2001 A1
20010037126 Stack et al. Nov 2001 A1
20010039452 Zucherman et al. Nov 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20010049530 Culbert et al. Dec 2001 A1
20020001476 Nagamine et al. Jan 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020055740 Lieberman May 2002 A1
20020087152 Mikus et al. Jul 2002 A1
20020091387 Hoogland Jul 2002 A1
20020120335 Angelucci et al. Aug 2002 A1
20020143331 Zucherman et al. Oct 2002 A1
20020143334 von Hoffmann et al. Oct 2002 A1
20020143335 von Hoffmann et al. Oct 2002 A1
20020151895 Soboleski et al. Oct 2002 A1
20020161444 Choi Oct 2002 A1
20020183848 Ray et al. Dec 2002 A1
20030028250 Reiley et al. Feb 2003 A1
20030063582 Mizell et al. Apr 2003 A1
20030065330 Zucherman et al. Apr 2003 A1
20030065396 Michelson Apr 2003 A1
20030069582 Culbert et al. Apr 2003 A1
20030083688 Simonson May 2003 A1
20030139648 Foley et al. Jul 2003 A1
20030139813 Messerli et al. Jul 2003 A1
20030187431 Simonson Oct 2003 A1
20030208122 Melkent et al. Nov 2003 A1
20030208220 Worley et al. Nov 2003 A1
20030220643 Ferree Nov 2003 A1
20030229350 Kay Dec 2003 A1
20030233102 Nakamura et al. Dec 2003 A1
20040006391 Reiley Jan 2004 A1
20040008949 Liu et al. Jan 2004 A1
20040019359 Worley et al. Jan 2004 A1
20040024463 Thomas et al. Feb 2004 A1
20040049190 Biedermann et al. Mar 2004 A1
20040049223 Nishtala et al. Mar 2004 A1
20040054412 Gerbec et al. Mar 2004 A1
20040059339 Roehm, III et al. Mar 2004 A1
20040059350 Gordon et al. Mar 2004 A1
20040097924 Lambrecht et al. May 2004 A1
20040097941 Weiner et al. May 2004 A1
20040097973 Loshakove et al. May 2004 A1
20040106925 Culbert Jun 2004 A1
20040127906 Culbert et al. Jul 2004 A1
20040133280 Trieu Jul 2004 A1
20040143284 Chin Jul 2004 A1
20040143734 Buer et al. Jul 2004 A1
20040147877 Heuser Jul 2004 A1
20040147950 Mueller et al. Jul 2004 A1
20040153156 Cohen Aug 2004 A1
20040158258 Bonati et al. Aug 2004 A1
20040162617 Zucherman et al. Aug 2004 A1
20040172134 Berry Sep 2004 A1
20040186471 Trieu Sep 2004 A1
20040186482 Kolb et al. Sep 2004 A1
20040199162 von Hoffmann et al. Oct 2004 A1
20040215343 Hochschuler et al. Oct 2004 A1
20040215344 Hochschuler et al. Oct 2004 A1
20040220580 Johnson et al. Nov 2004 A1
20040225292 Sasso et al. Nov 2004 A1
20040225361 Glenn et al. Nov 2004 A1
20040243239 Taylor Dec 2004 A1
20040249466 Liu et al. Dec 2004 A1
20040254575 Obenchain et al. Dec 2004 A1
20040260297 Padget et al. Dec 2004 A1
20040266257 Ries et al. Dec 2004 A1
20050033434 Berry Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050065610 Pisharodi Mar 2005 A1
20050090443 Michael John Apr 2005 A1
20050090833 DiPoto Apr 2005 A1
20050102202 Linden et al. May 2005 A1
20050113927 Malek May 2005 A1
20050118550 Turri Jun 2005 A1
20050119657 Goldsmith Jun 2005 A1
20050130929 Boyd Jun 2005 A1
20050131406 Reiley et al. Jun 2005 A1
20050131409 Chervitz et al. Jun 2005 A1
20050131411 Culbert et al. Jun 2005 A1
20050131538 Chervitz et al. Jun 2005 A1
20050137595 von Hoffmann et al. Jun 2005 A1
20050143734 Cachia et al. Jun 2005 A1
20050149030 Serhan Jul 2005 A1
20050154467 Peterman et al. Jul 2005 A1
20050165398 Reiley Jul 2005 A1
20050171552 Johnson et al. Aug 2005 A1
20050171608 Peterman et al. Aug 2005 A1
20050171610 Humphreys et al. Aug 2005 A1
20050177240 Blain Aug 2005 A1
20050182414 Manzi et al. Aug 2005 A1
20050182418 Boyd et al. Aug 2005 A1
20050187558 Johnson et al. Aug 2005 A1
20050187559 Raymond et al. Aug 2005 A1
20050203512 Hawkins et al. Sep 2005 A1
20050216026 Culbert Sep 2005 A1
20050251142 von Hoffmann et al. Nov 2005 A1
20050256525 Warren et al. Nov 2005 A1
20050278026 Gordon et al. Dec 2005 A1
20050283238 Reiley Dec 2005 A1
20060004326 Collins et al. Jan 2006 A1
20060004457 Collins et al. Jan 2006 A1
20060004458 Collins et al. Jan 2006 A1
20060009778 Collins et al. Jan 2006 A1
20060009779 Collins et al. Jan 2006 A1
20060009851 Collins et al. Jan 2006 A1
20060015105 Warren et al. Jan 2006 A1
20060020284 Foley et al. Jan 2006 A1
20060030872 Culbert et al. Feb 2006 A1
20060036246 Carl et al. Feb 2006 A1
20060036256 Carl et al. Feb 2006 A1
20060036259 Carl et al. Feb 2006 A1
20060036323 Carl et al. Feb 2006 A1
20060036324 Sachs et al. Feb 2006 A1
20060041314 Millard Feb 2006 A1
20060058790 Carl et al. Mar 2006 A1
20060058807 Landry et al. Mar 2006 A1
20060058880 Wysocki et al. Mar 2006 A1
20060079908 Lieberman Apr 2006 A1
20060084977 Lieberman Apr 2006 A1
20060084988 Kim Apr 2006 A1
20060085010 Lieberman Apr 2006 A1
20060100707 Stinson et al. May 2006 A1
20060106381 Ferree et al. May 2006 A1
20060122609 Mirkovic et al. Jun 2006 A1
20060122610 Culbert et al. Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060142765 Dixon et al. Jun 2006 A9
20060142776 Iwanari Jun 2006 A1
20060161166 Johnson et al. Jul 2006 A1
20060178743 Carter Aug 2006 A1
20060195103 Padget et al. Aug 2006 A1
20060217711 Stevens et al. Sep 2006 A1
20060229629 Manzi et al. Oct 2006 A1
20060235403 Blain Oct 2006 A1
20060235412 Blain Oct 2006 A1
20060247634 Warner et al. Nov 2006 A1
20060276899 Zipnick et al. Dec 2006 A1
20060276901 Zipnick et al. Dec 2006 A1
20060276902 Zipnick et al. Dec 2006 A1
20060293662 Boyer, II et al. Dec 2006 A1
20060293663 Walkenhorst et al. Dec 2006 A1
20070010826 Rhoda Jan 2007 A1
20070016191 Culbert et al. Jan 2007 A1
20070032790 Aschmann et al. Feb 2007 A1
20070055236 Hudgins et al. Mar 2007 A1
20070067035 Falahee Mar 2007 A1
20070073399 Zipnick et al. Mar 2007 A1
20070118132 Culbert et al. May 2007 A1
20070118223 Allard et al. May 2007 A1
20070123868 Culbert et al. May 2007 A1
20070123891 Ries et al. May 2007 A1
20070123892 Ries et al. May 2007 A1
20070129730 Woods et al. Jun 2007 A1
20070162005 Peterson et al. Jul 2007 A1
20070168036 Ainsworth et al. Jul 2007 A1
20070203491 Pasquet et al. Aug 2007 A1
20070233083 Abdou Oct 2007 A1
20070233089 DiPoto et al. Oct 2007 A1
20070270954 Wu Nov 2007 A1
20070270968 Baynham et al. Nov 2007 A1
20070282449 de Villiers Dec 2007 A1
20080058598 Ries et al. Mar 2008 A1
20080077148 Ries et al. Mar 2008 A1
20080082172 Jackson Apr 2008 A1
20080097436 Culbert et al. Apr 2008 A1
20080108996 Padget et al. May 2008 A1
20080140207 Olmos et al. Jun 2008 A1
20080147193 Matthis et al. Jun 2008 A1
20080255618 Fisher et al. Oct 2008 A1
20080262619 Ray Oct 2008 A1
20080287981 Culbert et al. Nov 2008 A1
20080287997 Altarac et al. Nov 2008 A1
20080300685 Carls et al. Dec 2008 A1
20080306537 Culbert et al. Dec 2008 A1
20090069813 von Hoffmann et al. Mar 2009 A1
20090105745 Culbert et al. Apr 2009 A1
20090131986 Lee et al. May 2009 A1
20090149857 Culbert et al. Jun 2009 A1
20090182429 Humphreys et al. Jul 2009 A1
20090222100 Cipoletti et al. Sep 2009 A1
20090275890 Leibowitz et al. Nov 2009 A1
20090292361 Lopez Nov 2009 A1
20100040332 Van Den Meersschaut et al. Feb 2010 A1
20100076492 Warner et al. Mar 2010 A1
20100082109 Greenhalgh Apr 2010 A1
20100114147 Biyani May 2010 A1
20100174314 Mirkovic Jul 2010 A1
20100191336 Greenhalgh Jul 2010 A1
20100211176 Greenhalgh Aug 2010 A1
20100268231 Kuslich Oct 2010 A1
20100292700 Ries Nov 2010 A1
20100292796 Greenhalgh et al. Nov 2010 A1
20100298938 Humphreys et al. Nov 2010 A1
20100331891 Culbert et al. Dec 2010 A1
20110054538 Zehavi et al. Mar 2011 A1
20110071527 Nelson et al. Mar 2011 A1
20110098531 To Apr 2011 A1
20110098628 Yeung et al. Apr 2011 A1
20110130838 Morgenstern Lopez Jun 2011 A1
20110153020 Abdelgany Jun 2011 A1
20110172774 Varela Jul 2011 A1
20110238072 Tyndall Sep 2011 A1
20110251690 Berger Oct 2011 A1
20110282453 Greenhalgh Nov 2011 A1
20110307010 Pradhan Dec 2011 A1
20110313465 Warren et al. Dec 2011 A1
20110319997 Glerum et al. Dec 2011 A1
20120059474 Weiman Mar 2012 A1
20120059475 Weiman Mar 2012 A1
20120150304 Glerum Jun 2012 A1
20120150305 Glerum Jun 2012 A1
20120158146 Glerum Jun 2012 A1
20120158147 Glerum Jun 2012 A1
20120158148 Glerum Jun 2012 A1
20120185049 Varela Jul 2012 A1
20120197405 Cuevas Aug 2012 A1
20120203290 Warren et al. Aug 2012 A1
20120203347 Glerum Aug 2012 A1
20120215262 Culbert et al. Aug 2012 A1
20120226357 Varela Sep 2012 A1
20120232552 Lopez et al. Sep 2012 A1
20120232658 Lopez et al. Sep 2012 A1
20120265309 Glerum et al. Oct 2012 A1
20120277795 Hoffmann Nov 2012 A1
20120290090 Glerum Nov 2012 A1
20120290097 Cipoletti Nov 2012 A1
20120323328 Weiman Dec 2012 A1
20120330421 Weiman Dec 2012 A1
20120330422 Weiman Dec 2012 A1
20130006361 Glerum Jan 2013 A1
20130023993 Weiman Jan 2013 A1
20130023994 Glerum Jan 2013 A1
20130197642 Ernst Aug 2013 A1
20130197647 Wolters et al. Aug 2013 A1
20140236296 Wagner et al. Aug 2014 A1
20140277473 Perrow Sep 2014 A1
Foreign Referenced Citations (68)
Number Date Country
2005-314079 Oct 2012 AU
1177918 Apr 1998 CN
3 023 353 Apr 1981 DE
198 32 798 Nov 1999 DE
201 01 793 May 2001 DE
0 077 159 Apr 1983 EP
0 260 044 Mar 1988 EP
0 433 717 Jun 1991 EP
0 525 352 Feb 1993 EP
0 611 557 Aug 1994 EP
0 625 336 Nov 1994 EP
1 046 376 Apr 2000 EP
0 853 929 Sep 2002 EP
1 378 205 Jul 2003 EP
1 374 784 Jan 2004 EP
2 331 023 Jun 2011 EP
1 845 874 Oct 2012 EP
200801551 May 2008 ES
2 699 065 Dec 1992 FR
2 728 778 Dec 1994 FR
2 745 709 Mar 1996 FR
2 800 601 Nov 1999 FR
2 801 189 Nov 1999 FR
2 808 182 Apr 2000 FR
2157788 Oct 1985 GB
2173565 Oct 1986 GB
64-52439 Feb 1989 JP
6-500039 Jun 1994 JP
6-319742 Nov 1994 JP
07-502419 Mar 1995 JP
07-184922 Jul 1995 JP
10-085232 Apr 1998 JP
11-089854 Apr 1999 JP
2011-520580 Jul 2011 JP
4988203 Aug 2012 JP
5164571 Dec 2012 JP
WO 9109572 Dec 1989 WO
WO 9304652 Mar 1993 WO
WO 9628100 Sep 1996 WO
WO 9952478 Oct 1999 WO
WO 9962417 Dec 1999 WO
WO 0067652 May 2000 WO
WO 0076409 Dec 2000 WO
WO 0112054 Feb 2001 WO
WO 0180751 Nov 2001 WO
WO 0243601 Jun 2002 WO
WO 03021308 Mar 2003 WO
WO 03043488 May 2003 WO
WO 2004008949 Jan 2004 WO
WO 2004064603 Aug 2004 WO
WO 2004078220 Sep 2004 WO
WO 2004078221 Sep 2004 WO
WO 2004098453 Nov 2004 WO
WO 2005112835 Dec 2005 WO
WO 2006017507 Feb 2006 WO
WO 2006063083 Jun 2006 WO
WO 2006108067 Oct 2006 WO
WO 2007119212 Oct 2007 WO
WO 2007124130 Apr 2008 WO
WO 2008044057 Apr 2008 WO
WO 2008064842 Jun 2008 WO
WO 2008070863 Jun 2008 WO
WO 2009152919 Dec 2009 WO
WO 2010136170 Dec 2010 WO
WO 2010148112 Dec 2010 WO
WO 2011079910 Jul 2011 WO
WO 2011142761 Nov 2011 WO
WO 2011150350 Dec 2011 WO
Non-Patent Literature Citations (56)
Entry
Jan. 26, 2005 International Search Report and Written Opinion received in corresponding PCT App. No. PCT/US04/06129, 13 pages.
Aug. 4, 2005 EPO Examination Report for App. No. 01 932 643.8.
Sep. 19, 2005 Office Action received in Australian Application No. 2002250488 filed Mar. 29, 2002.
Apr. 13, 2006 International Search Report for App. No. PCT/US2005/044321.
Jun. 22, 2006 European Search Report for Application No. 02719402.6 filed Mar. 29, 2002.
Apr. 6, 2007 Office Action received in Chinese Application No. 02810329.7 filed Mar. 29, 2002.
Apr. 22, 2004 International Search Report for App. No. PCT/US03/23645 filed Jul. 18, 2003.
Apr. 18, 2007 EPO Examination Report for App. No. 01 932 643.8.
Apr. 19, 2007 Office Action for European Application No. 02 719 402.6 filed Mar. 29, 2002.
Apr. 19, 2007 Office Action Communication for Application No. 02719402.6 filed on Mar. 29, 2002.
Jun. 18, 2007 Notice of Acceptance received in Australian Application No. 2002250488 filed Mar. 29, 2002.
Jan. 9, 2008 Supplemental Partial European Search Report received in corresponding European Application No. 0 471 618.
Apr. 17, 2008 International Search Report and Written Opinion from corresponding PCT Application No. PCT/US07/09794 filed Apr. 20, 2007 in 8 pages.
Apr. 22, 2008 Supplemental ISR rec'd in corresponding EP Application No. 04716129.4.
Apr. 29, 2008 Notice for Preliminary Rejection in Korean Application No. 2003-7012847 filed Mar. 29, 2002.
May 30, 2008 International Search Report & Written Opinion received in corresponding PCT Application No. PCT/US06/12728 in 9 pgs.
Jul. 3, 2008 Office Action received for Canadian Application No. 2,442,334 filed Mar. 29, 2002.
Jul. 7, 2008 International Search Report and Written Opinion received in co-pending PCT Application No. PCT/US2005/027431 filed Aug. 2, 2005.
Jul. 7, 2008 International Search Report and Written Opinion received in co-pending PCT Application No. PCT/US2007/086866 filed Dec. 7, 2007.
Mar. 12, 2009 International Preliminary Report on Patentability, received in corresponding PCT Application No. PCT/US2007/009794 filed Apr. 20, 2007, in 5 pages.
Apr. 3, 2009 Extended European Search Report received in European Application No. 09152476.9 in 5 pages.
May 25, 2009 Notice of Allowance received in Canadian Application No. 2,442,334 filed Mar. 29, 2002.
May 27, 2009 Office Action for Japanese Patent Application No. 2005-50552 filed on Jul. 18, 2003.
Jun. 18, 2009 Preliminary Report on Patentability received in co-pending PCT Application No. PCT/US2007/086866 filed Dec. 7, 2007.
Jul. 2, 2009 Office Action for U.S. Appl. No. 11/308,767 filed on May 1, 2006.
Aug. 4, 2009 Extended European Search Report received in European Application No. 09164698.4, 5 pages.
Sep. 7, 2009 Office Action for European Application No. 05 853 282.1filed Dec. 8, 2005.
Mar. 31, 2010 Office Action for Japanese Patent Application No. 2005-505552 filed on Jul. 18, 2003.
Apr. 20, 2010 International Search Report and Written Opinion in co-pending PCT Application No. PCT/IB2009/005972 in 19 pages.
Sep. 10, 2010 Supplementary European Search Report of European Application No. EP 0 674 0 578 filed on Apr. 4, 2006.
Jan. 27, 2011 Office Action for Australian Application No. 2005314079 filed Dec. 8, 2005.
Feb. 7, 2011 Office Action for Japanese Application No. 2007-524917 filed Aug. 2, 2005.
Feb. 24, 2012 Office Action for Japanese Application No. 2007-524917 filed Aug. 2, 2005.
Mar. 23, 2011 Office Action for Japanese Application No. 2005-505552 filed Jul. 18, 2003.
Jul. 5, 2011 Office Action (Rejection Notice dispatched Jul. 13, 2011) for Japanese Application No. 2007-545602.
Apr. 28, 2011 Supplementary European Search Report for Application No. EP 07 75 5880 filed on Apr. 20, 2007.
Mar. 14, 2012 Supplemental European Search Report for Application No. EP 05 77 7628.
Apr. 2, 2012 Office Action (to proceed and to respond to Search Report) for Application No. 05777628.8.
May 25, 2012 Office Action for EP Application No. 04716128.6.
Jun. 25, 2012 International Search Report and Written Opinion for PCT Application No. PCT/US2012/02811 0, the PCT counterpart of the present application.
Alfen, et al., “Developments in the Area of Edoscopic Spine Surgery”. European Musculoskeletal Review 2006, pp. 23-24. ThessysTM, Transforminal Endoscopic Spine System. Medical Solutions, ioimax®.
Brooks, M.D., et al. Efficacy of Supplemental Posterior Transfacet Pedicle Device Fixation in the Setting of One—or Two-Level Anterior Lumbar Interbody Fusion Brochure for PERPOS PLS System Surgical Technique by Interventional Spine.
Paul D. Fuchs, “The Use of an Interspinous Implant in Conjunction With a Graded Facetectomy Procedure”, SPINE vol. 30, No. 11, pp. 1266-1272.
Iprenburg, et al., “Transforaminal Endoscopic Surgery in Lumbar Disc Herniation in an Economic Crisis—The TESSYS Method”. US Musculoskeletal, 2008 pp. 47-49.
King, M.D., Don, “Internal Fixation for Lumbosacral Fusion”, The Journal of Bone and Joint Surgery. J Bone Joint Surg Am. 1948; 30:560-578.
Medco Forum, “Percutaneous Lumbar Fixation Via PERPOS PLS System Interventional Spine”. Sep. 2008, vol. 15, No. 37.
Medco Forum, “Percutaneous Lumbar Fixation via PERPOS System From Interventional Spine”. Oct. 2007, vol. 14, No. 49.
Mahar, et al. Biomechanical Comparison of a Novel Percutaneous Transfacet Device and a Traditional Posterior System for Single Level Fusion. Journal of Spinal Disorders & Techniques, Dec. 2006, vol. 19 No. 8, pp. 591-594.
Morgenstern R; Transforaminal Endoscopic Stenosis Surgery—A Comparative Study of Laser and Reamed Foraminoplasty.In: European Musculoskeletal Review, Issue 1,2009.
ProMapTM EMG Navigation Probe. Technical Brochure Spineology Inc., Dated May 2009.
Chin, Kingsley R., M.D. “Early Results of the Triage Medical Percutaneous Transfacet Pedicular BONE-LOK Compression Device for Lumbar Fusion”.
Niosi, Christina A., “Biomechanical characterization of the three-dimentional kinematic behaviour of the Dynesys dynamic stabilization system: an in vitro study”, Eur Spine J (2006) 15: pp. 913-922.
Manal Siddiqui, “The Positional Magnetic Resonance Imaging Changes in the Lumbar Spine Following Insertion of a Novel Interspinous Process Distraction Device”, SPINE vol. 30, No. 23, pp. 2677-2682.
Vikram Talwar, “Insertion loads of the X STOP interspinous process distraction system designed to treat neurogenic intermittent claudication”, Eur Spine J (2006) 15: pp. 908-912.
James F. Zucherman, “A Multicenter, Prospective, Randomized Trial Evaluating the X STOP Interspinous Process Decompression System for the Treatment of Neurogenic Intermittent Claudication”, SPINE vol. 30, No. 12, pp. 1351-1358.
Kambin, et al; Percutanseous Lateral Discectomy of the Lumbar Spine: A Preliminary Report; Clin. Orthop.; 1983; 174: 127-132.
Related Publications (1)
Number Date Country
20140257484 A1 Sep 2014 US